Rituximab as a treatment alternative in sarcoidosis

Joint Bone Spine

Volumn 75, Issue 4, 2008, Pages 511-512

  Belkhou, Ahlam ^a   Younsi, Rachid ^a   El Bouchti, Imane ^a   El Hassani, Selma ^a  

^a Service de rhumatologie   (Morocco)

Author keywords

Anti CD20 antibodies; Rituximab; Sarcoidosis

Indexed keywords

METHOTREXATE; PREDNISONE; RITUXIMAB;

ADULT; AUTOIMMUNE DISEASE; B CELL LYMPHOMA; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEADACHE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTENSION; LETTER; MALAISE; RASH; RHEUMATOID ARTHRITIS; SARCOIDOSIS; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; FEMALE; HUMANS; SARCOIDOSIS; TREATMENT OUTCOME;

EID: 46449111363     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2008.01.025     Document Type: Letter

References (4)

1. Falgarone G., Dumont Fischer D., and Boissier M.C. Rituximab et maladies auto-immunes. Actualité rhumatologique (2005) 341-354
2. Gepner P., Brousse C., Epardeau B., et al. Alternance sarcoïdose/lymphome non hodgkinien? Association fortuite ou lien pathogénique?. Rev Med Interne 6 suppl 1 (1992) S156
3. Taillan B., Pedinielli F.J., Routy J.P., et al. Lymphome malin non hodgkinien et anémie auto-immune au cours de l'évolution de la sarcoïdose. Rev Med Interne 6 (1985) 573-575
4. Gottenberg J., Guillevin L., Lambotte O., et al. Tolerance and short-term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis 64 (2005) 913-920